Last reviewed · How we verify
Fetal Life: Smart-Device Based Uterine Activity Monitoring
This study will compare the performance of a contraction monitor (tocometer) device developed by Fetal Life with standard tocometer devices. The study aims to test a uterine contraction monitor that can be applied by the patient to her abdomen and connected to her smart device to detect the frequency and duration of uterine contractions. Phase 1 will collect data for calibration of the monitor and for a noninferiority study comparing the Fetal Life uterine contraction monitor (tocometer) with standard tocometry devices. Phase 2 will be a feasibility study in which patients will position the monitor, connect to the corresponding Fetal Life app and measure their own uterine contraction activity. The study's hypothesis is that after calibration, the new monitor will reliably detect at least 95% of the number and duration of contractions detected by the standard monitor, and that the device will perform comparably whether applied by the patient or by research staff.
Details
| Lead sponsor | Fetal Life LLC |
|---|---|
| Phase | NA |
| Status | COMPLETED |
| Enrolment | 17 |
| Start date | Wed May 15 2019 00:00:00 GMT+0000 (Coordinated Universal Time) |
| Completion | Wed Mar 31 2021 00:00:00 GMT+0000 (Coordinated Universal Time) |
Conditions
- Labor Pain
- Contraction
Interventions
- Fetal Life tocometer device
Countries
United States